<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:chebi fb="0" ids="51240">Propidium iodide</z:chebi> staining was used to examine cell cycle parameters (G(0)/G(1), S and G(2)/M) of bone marrow mononuclear cells (BMMNCs) while immunofluorescent double staining and FACS techniques were used to measure Ki67 expression in BM CD34+ cells from <z:mpath ids='MPATH_458'>normal</z:mpath> control, patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> preceded by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: There was a statistical up-tendency in G(0)/G(1) phase proportion of BMMNCs whereas a statistical down-tendency in S and G(2)/M phase proportions among <z:mpath ids='MPATH_458'>normal</z:mpath> control, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Compared to primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> had significantly higher ratios of S (P &lt; 0.05), G(2)/M (P &lt; 0.05) and S + G(2)/M (P &lt; 0.05) phase cells while lower ratio of G(0)/G(1) phase cells (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The proportion of CD34+Ki67+ cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients was significantly higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> control (P = 0.004) </plain></SENT>
<SENT sid="5" pm="."><plain>So were the percentages of CD34+Ki67+ cells in low-risk [(0.54 +/- 0.49)%, P &lt; 0.05] and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients [(1.69 +/- 1.66)%, P = 0.022] </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, there was statistical difference between low-risk and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to <z:mpath ids='MPATH_458'>normal</z:mpath> control and primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-patients had the highest proportion of CD34+Ki67+ cells [(16.75 +/- 13.58)%, P &lt; 0.05] </plain></SENT>
<SENT sid="8" pm="."><plain>The proportion of CD34+Ki67+ cells in CD34+ cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients [(48.50 +/- 20.49)%] was significantly higher than that in <z:mpath ids='MPATH_458'>normal</z:mpath> control [(27.71 +/- 16.04)%, P &lt; 0.01] </plain></SENT>
<SENT sid="9" pm="."><plain>So were the low-risk [(51.85 +/- 21.80)%, P = 0.002] and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> [(43.93 +/- 18.57)%, P &lt; 0.05] </plain></SENT>
<SENT sid="10" pm="."><plain>The proportion of CD34+Ki67+ cells in CD34+ cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients [(60.92 +/- 30.12)%] was the highest, and was statistically higher than that in both <z:mpath ids='MPATH_458'>normal</z:mpath> control (P &lt; 0.01) and primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients [(17.01 +/- 15.93)%, P &lt; 0.001] </plain></SENT>
<SENT sid="11" pm="."><plain>The proportion of CD34+Ki67+ cells in Ki67+ cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients [(4.91 +/- 4.68)%, P &lt; 0.01] was significantly higher than that [(2.43 +/- 2.37)%] in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="12" pm="."><plain>In the low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group it was (4.11 +/- 3.94)%, (P &gt; 0.05) and in high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group it was (5.76 +/- 5.38)%, (P &lt; 0.05) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: High proportion of G(0)/G(1) cells and G(1) phase arrest occurred in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>High proliferation capacity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> clone, especially that derived from CD34+ cells, might play an important role in the clonal expansion, diseases deterioration and worse prognosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>